Non-timely reporting, selective reporting, or non-reporting of clinical trial results are
prevalent and serious issues. WHO mandates that summary results be available in registries …

Introduction COVID-19 caused by SARS-CoV-2, commonly presents with symptoms such as
fever and shortness of breath but can also affect other organs. There is growing evidence …

Introduction: The accurate number of COVID-19 cases is essential knowledge to control an
epidemic. Currently, one of the most important obstacles in estimating the exact number of …

Background Since the breakthrough of the pandemic, several drugs have been used to treat
COVID‐19 patients. This review aims to gather information on adverse events (AE) related to …

The literature on coronavirus disease 2019 (COVID-19) treatments, including herbal
medicine, has expanded rapidly due to intense global interest. We conducted this scoping …

From its outbreak in early 2020, the new SARS-CoV-2 infection has deeply affected the
entire eye care system for several reasons. Since the beginning of the COVID-19 pandemic …

With the global death toll nearing 3.3 million, India being amongst the top 4 countries, the
condition is more than fearsome. World Health Organization (WHO) recommends one doctor …

Background: The Clinical Trials Registry-India (CTRI) database is a registry of various trials
conducted in India and this study scrutinized the studies registered for COVID-19 from the …

ABSTRACT OBJECTIVES To assess the efficacy and safety of convalescent plasma plus
standard of care (CP+ SoC) compared with standard of care (SoC) alone in patients …

From the perspective of repurposing medication, recent evidence suggests that the use of
selective serotonin reuptake inhibitor antidepressants (SSRIs) can help reduce the severity …